Venn: Your partner in Drug Development and Resourcing Solutions
European Focus – International Coverage
Venn Life Sciences is an Integrated Drug Development Partner offering a unique combination of drug and device development expertise and clinical trial design and management. This enables us to create, plan and execute drug and medical device development programs effectively and seamlessly for our clients.
“We have been delighted to work with Venn Life Sciences on this complex clinical trial. Their commitment to quality coupled with an in-depth knowledge of running Investigator Initiated Studies has facilitated the effective and efficient management of the various activities and requirements associated with the study. We fully expect that together we will bring the trial to completion on time and on budget.”
Professor Keith G. Oldroyd, Director of Research and Development West of Scotland Regional Heart & Lung Centre, Golden Jubilee National Hospital
Westminster, London - 13 December QEII Centre. Under the overarching theme of Driving success in Life Sciences & Healthcare: Convergence of Technology, Investment
Westminster, London – 13 December QEII Centre.
Under the overarching theme of Driving success in Life Sciences & Healthcare: Convergence of Technology, Investment and Talent our 18th Annual Genesis Conference, will take place on Thursday 13 December 2018 in London. The event will again engage all the key elements for those active in R&D, finance, policy making and service provision across Life Sciences, Digital and Health Technology fields in creating a vision of where the sector is heading. Over 70 expert speakers and panellists will lead sessions discussing which approaches will deliver better outcomes for patients, investors and payers.